This inventor holds 1 USPTO granted patent. Top assignees: Medical University of Innsbruck, University of Innsbruck. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 12 
1 out of 17 Years Active: 2022
Title: Isabel Delazer: Innovator in Nucleotide Conversion
Introduction
Isabel Delazer is a prominent inventor based in Innsbruck, Austria. She has made significant contributions to the field of biochemistry, particularly in the conversion of nucleotides. Her innovative work has implications for genetic research and molecular biology.
Latest Patents
Isabel Delazer holds a patent titled "Osmiumtetroxide-based conversion of RNA and DNA containing thiolated nucleotides." This patent provides compositions and methods for the conversion of thiolated nucleotides, along with subsequent detection of the converted nucleotides in RNA or DNA. Additionally, it includes methods for the metabolic labeling of RNA and DNA through the incorporation of thiolated nucleotides, followed by their conversion and detection.
Career Highlights
Throughout her career, Isabel has worked at esteemed institutions such as the University of Innsbruck and the Medical University of Innsbruck. Her research has focused on advancing the understanding of nucleotide chemistry and its applications in various scientific fields.
Collaborations
Isabel has collaborated with notable colleagues, including Ronald Micura and Alexandra Lusser. These partnerships have enriched her research and contributed to the advancement of her innovative projects.
Conclusion
Isabel Delazer's work in nucleotide conversion showcases her dedication to scientific innovation. Her contributions continue to influence the fields of biochemistry and molecular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile